Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 205 results found. Search for [ bharat biotech's covaxin ]

Results 100 to 120 of 205
Reuters
December 27, 2020
Coronavirus vaccine: Russia launched a voluntary vaccination programme with the Russia-made Sputnik V vaccine earlier in December, starting with the most vulnerable groups in Moscow


PTI
December 27, 2020
Serum Institute of India (SII) has made a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine. The SII has already manufactured 40 million doses of the vaccine


BusinessToday.In
New Delhi, December 25, 2020
Delhi Chief Minister Arvind Kejriwal said that the capital is fully ready to receive, store and give coronavirus vaccine to \"priority category\" people in the first phase of vaccination; Air India pilots have refused to accept the 'paltry' 5 per cent roll back in the 'illegal pay cut' by the carrier; All India Institute of Medical Sciences, one of the sites for the coronavirus vaccine trials for Bharat Biotech's candidate Covaxin, has put up advertisements inviting volunteers to enroll for the Phase 3 trials. Watch this and more on News Blast.Also Read: COVID stress boosts digital selling among micro, small enterprises: CRISIL


Shailendra Shukla
New Delhi, December 25, 2020
51 lakh people in Delhi to receive coronavirus vaccine in phase-1 of vaccinationDelhi Chief Minister Arvind Kejriwal said that the capital is fully ready to receive, store and give coronavirus vaccine to \"priority category\" people in the first phase of vaccination. The CM said that he has identified 51 lakh people who will be the first ones to get vaccinated under the \"priority category\", which includes frontline workers, health workers, and people above 50 or having co-morbidities.Coro...


Reuters
December 24, 2020
Brazil is the first country to complete a late-stage trial of the vaccine, called CoronaVac, but a release of the results, first set for early December, has now been delayed three times


BusinessToday.In
December 24, 2020
Coronavirus vaccine trials: Earlier officials had said that people are unwilling to participate in the exercise thinking why take part in the trials when the vaccine would soon be available for everybody


PTI
December 24, 2020
Covaxin, being developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is now undergoing phase-3 trials


BusinessToday.In
December 22, 2020
The Phase 3 clinical trials of Covaxin began in mid-November with a target of 26,000 volunteers. Bharat Biotech's is the first and only Phase 3 efficacy study for a vaccine developed in the country


BusinessToday.In
December 21, 2020
COVID-19 vaccine update: Six vaccines are undergoing trials in the country and are in different phases of development


PTI
December 18, 2020
The All India Institute of Medical Sciences (AIIMS) in the national capital is one of the sites conducting the final phase of the trial of the vaccine, \"Covaxin\", and it needs around 1,500 volunteers for the purpose


BusinessToday.In
December 16, 2020
As of now, the Hyderabad-based manufacturer is in Phase III of its candidate's clinical trials, having over 25,800 volunteers across 18 sites in the country


BusinessToday.In
December 16, 2020
Last month, 67-year-old Anil Vij volunteered himself for Bharat Biotech's coronavirus vaccine trial. The firebrand BJP leader had offered to be the first volunteer in the phase three trials for Covaxin


Rashi Bisaria
New Delhi, December 14, 2020
Foreign banks, capital from abroad can remedy India's bad debt: Abhijit Banerjee As discussion continues whether private players should be allowed in the Indian banking space, Nobel laureate Abhijit Banerjee pointed out how foreign participation can save the bleeding sector. Banerjee said that Indian banks need a huge capital infusion to stay viable that can come easily from foreign sources. Banerjee noted that once we take on the view that the banking sector needs more private ownership, r...


BusinessToday.In
December 13, 2020
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) sought additional safety and efficacy data for COVID-19 vaccine candidates of Bharat Biotech after deliberating upon its applications seeking emergency use authorisation for the shots


PB Jayakumar
December 11, 2020
As the country plans to vaccinate 30 crore people by July in the first phase, it may be difficult to bank alone on the Indian vaccines, especially Serum Institute's (SII) Covishield


BusinessToday.In
December 9, 2020
Several experts have raised questions about Bharat Biotech applying for emergency usage as Covaxin is still going through an efficacy trial. However, the ICMR has backed Bharat Biotech's move


PTI
December 8, 2020
All India Bank Officers' Confederation (AIBOC), All India Bank Officers' Association (AIBOA), Indian National Bank Officers' Congress (INBOC) and National Organisation of Bank Officers (NOBO) have jointly written the letter to the finance minister


BusinessToday.In
December 7, 2020
After American drug maker Pfizer and Pune-based Serum Institute, Bharat Biotech is the third company to apply for emergency use authorisation for its COVID-19 vaccine to the DCGI


PTI
December 6, 2020
The protest in Bay Area was organised by the Jakara Movement, a California-based grassroots organisation which seeks to strengthen community engagement and build empowerment by focusing on issues of civic engagement, education, health, and social justice.


PTI
December 5, 2020
Lok Sabha Speaker Om Birla said that PM Modi wil lay foundation stone of the new Parliament building and the construction is expected to be completed by 2022 at an estimated cost of Rs 971 crore


PAGES 6 OF 11  678910